Cellosaurus logo
expasy logo

Cellosaurus SBC-3/ADM100 (CVCL_UW53)

[Text][XML][JSON]
Cell line name SBC-3/ADM100
Synonyms SBC-3/ADM 100
Accession CVCL_UW53
Resource Identification Initiative To cite this cell line use: SBC-3/ADM100 (RRID:CVCL_UW53)
Comments Population: Japanese.
Doubling time: 46 hours (PubMed=8104372).
Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
Disease Lung small cell carcinoma (NCIt: C4917)
Small cell lung cancer (ORDO: Orphanet_70573)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_M841 (SBC-3/ADM)
Sex of cell Male
Age at sampling 24Y
Category Cancer cell line
Publications

PubMed=1442149; DOI=10.18926/AMO/32631
Nagio Takigawa, Taisuke Ohnoshi, Hiroshi Ueoka, Katsuyuki Kiura, Ikuro Kimura;
Comparison of antitumor activity of new anthracycline analogues, ME2303, KRN8602, and SM5887 using human lung cancer cell lines.
Acta Med. Okayama 46:249-256(1992)

PubMed=8104372; DOI=10.18926/AMO/31598
Katsuyuki Kiura, Taisuke Ohnoshi, Masahiro Tabata, Takuo Shibayama, Ikuro Kimura;
Establishment of an adriamycin-resistant subline of human small cell lung cancer showing multifactorial mechanisms of resistance.
Acta Med. Okayama 47:191-197(1993)

PubMed=9227790; DOI=10.18926/AMO/30795
Keisuke Matsuo, Katsuyuki Kiura, Hiroshi Ueoka, Masahiro Tabata, Takuo Shibayama, Tadashi Matsumura, Nagio Takigawa, Shunkichi Hiraki, Mine Harada;
Growth inhibitory effects of antifolates against an adriamycin-resistant human small cell lung cancer cell line.
Acta Med. Okayama 51:121-127(1997)

Cross-references
Encyclopedic resources Wikidata; Q98129349
Entry history
Entry creation25-Feb-2019
Last entry update27-Nov-2025
Version number8